Ginger (Zingiber officinale) prevents severe damage to the lungs due to hyperoxia and inflammation
Ginger (Zingiber officinale) prevents severe damage to the lungs due to hyperoxia and inflammation
Background/aim: Hyperoxia- and inflammation-induced lung injury is an important cause of the development of bronchopulmonarydysplasia (BPD) in premature infants. We aimed to ascertain the beneficial effects of ginger (Zingiber officinale) on rat pups exposed tohyperoxia and inflammation.Materials and methods: Thirty-six newborn Wistar rats were randomly divided into 3 groups as the hyperoxia (95% O2) +lipopolysaccharide (LPS) group, the hyperoxia + LPS + ginger-treated group, and the control/no treatment group (21% O2). Pups in thehyperoxia + LPS + ginger group were administered oral ginger at a dose of 1000 mg/kg daily during the study period. Histopathologic,immunochemical (SMA and lamellar body), and biochemical evaluations including total antioxidant status (TAS), total oxidantstatus (TOS), malondialdehyde (MDA), myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β),interleukin-6 (IL-6), and caspase-3 activities were performed.Results: Better weight gain and survival rates were shown in the hyperoxia + LPS + ginger group (P < 0.05). In the histopathologicand immunochemical evaluation, severity of lung damage was significantly reduced in the hyperoxia + LPS + ginger group, as wellas decreased apoptosis (ELISA for caspase-3) (P < 0.05). Tissue TAS levels were significantly protected, and TOS, MDA, and MPOlevels were significantly lower in the hyperoxia + LPS + ginger group (P < 0.05). Tissue TNF-α, IL-1β, and IL-6 concentrations weresignificantly decreased in the ginger-treated group (P < 0.05).Conclusion: Ginger efficiently reduced the lung damage and protected the lungs from severe damage due to hyperoxia and inflammation.Therefore, ginger may be an alternative option for the treatment of BPD.
___
- Van Marter LJ. Epidemiology of bronchopulmonary dysplasia.
Semin Fetal Neonatal Med 2009; 14: 358-366.
- Natarajan G, Pappas A, Shankaran S, Kendrick DE, Das
A, Higgins RD, Laptook AR, Bell EF, Stoll BJ, Newman N
et al. Outcomes of extremely low birth weight infants with
bronchopulmonary dysplasia: impact of the physiologic
definition. Early Hum Dev 2012; 88: 509-515.
- Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran
S, Laptook AR, Sánchez PJ, Van Meurs KP, Wyckoff M et al.
Trends in care practices, morbidity, and mortality of extremely
preterm neonates, 1993-2012. JAMA 2015; 314: 1039-1051.
- EXPRESS Group. Incidence of and risk factors for neonatal
morbidity after active perinatal care: Extremely Preterm Infants
Study in Sweden (EXPRESS). Acta Paediatr 2010; 99: 978-992.
- Niedermaier S, Hilgendorff A. Bronchopulmonary dysplasia -
an overview about pathophysiologic concepts. Mol Cell Pediatr
2015; 2: 2.
- Shahzad T, Radajewski S, Chao CM, Bellusci S, Ehrhardt
H. Pathogenesis of bronchopulmonary dysplasia: when
inflammation meets organ development. Mol Cell Pediatr 2016;
3: 23.
- Tropea K, Christou H. Current pharmacologic approaches for
prevention and treatment of bronchopulmonary dysplasia. Int J
Pediatr 2012; 2012: 598606.
- Ahmad B, Rehman MU, Amin I, Arif A, Rasool S, Bhat SA, Afzal
I, Hussain I, Bilal S, Mir MU. A review on pharmacological
properties of zingerone (4-(4-hydroxy-3-methoxyphenyl)-2-
butanone). Sci World J 2015; 2015: 816364.
- Xie X, Sun S, Zhong W, Soromou LW, Zhou X, Wei M, Ren
Y, Ding Y. Zingerone attenuates lipopolysaccharide-induced
acute lung injury in mice. Int Immunopharmacol 2014; 19:
103-109.
- Vahdat Shariatpanahi Z, Mokhtari M, Taleban FA, Alavi F,
Salehi Surmaghi MH, Mehrabi Y, Shahbazi S. Effect of enteral
feeding with ginger extract in acute respiratory distress
syndrome. J Crit Care 2013; 28: 217.e1-6.
- Shin IS, Lee MY, Jeon WY, Shin NR, Seo CS, Ha H. EBM84
attenuates airway inflammation and mucus hypersecretion
in an ovalbumin-induced murine model of asthma. Int J Mol
Med 2013; 31: 982-988.
- Tao Y, Li W, Liang W, Van Breemen RB. Identification
and quantification of gingerols and related compounds in
ginger dietary supplements using high-performance liquid
chromatography-tandem mass spectrometry. J Agric Food
Chem 2009; 57: 10014-10021.
- Ghasemzadeh A, Jaafar HZ, Rahmat A. Changes in antioxidant
and antibacterial activities as well as phytochemical
constituents associated with ginger storage and polyphenol
oxidase activity. BMC Complement Altern Med 2016; 16: 382.
- Salihu M, Ajayi BO, Adedara IA, Farombi EO. 6-Gingerolrich fraction from Zingiber officinale prevents hematotoxicity
and oxidative damage in kidney and liver of rats exposed to
carbendazim. J Diet Suppl 2016; 13: 433-448.
- Amri M, Touil-Boukoffa C. In vitro anti-hydatic and
immunomodulatory effects of ginger and [6]-gingerol. Asian Pac
J Trop Med 2016; 9: 749-756.
- Cheong KO, Shin DS, Bak J, Lee C, Kim KW, Je NK, Chung
HY, Yoon S, Moon JO. Hepatoprotective effects of zingerone on
carbon tetrachloride- and dimethylnitrosamine-induced liver
injuries in rats. Arch Pharm Res 2016; 39: 279-291.
- Molahosseini A, Taghavi MM, Taghipour Z, Shabanizadeh A,
Fatehi F, Kazemi Arababadi M, Eftekhar Vaghefe SH. The effect
of the ginger on the apoptosis of hippochampal cells according
to the expression of BAX and Cyclin D1 genes and histological
characteristics of brain in streptozotocin male diabetic rats. Cell
Mol Biol (Noisy-le-grand) 2016; 62: 1-5.
- Choi CW, Lee J, Oh JY, Lee SH, Lee HJ, Kim BI. Protective effect
of chorioamnionitis on the development of bronchopulmonary
dysplasia triggered by postnatal systemic inflammation in
neonatal rats. Pediatr Res 2016; 79: 287-94.
- Ni W, Lin N, He H, Zhu J, Zhang Y. Lipopolysaccharide induces
up-regulation of TGF-α through HDAC2 in a rat model of
bronchopulmonary dysplasia. PLoS One 2014; 9: e91083.
- Yang M, Liu C, Jiang J, Zuo G, Lin X, Yamahara J, Wang J, Li
Y. Ginger extract diminishes chronic fructose consumptioninduced kidney injury through suppression of renal
overexpression of proinflammatory cytokines in rats. BMC
Complement Altern Med 2014; 14: 174.
- Rong X, Peng G, Suzuki T, Yang Q, Yamahara J, Li Y. A 35-
day gavage safety assessment of ginger in rats. Regul Toxicol
Pharmacol 2009; 54: 118-123.
- Askenazi SS, Perlman M. Pulmonary hypoplasia: lung weight
and radial alveolar count as criteria of diagnosis. Arch Dis Child
1979; 54: 614-618.
- Ozer E, Sis B, Ozen E, Sakizli M, Canda T, Sarioglu S. BRCA1,
c-erbB-2 and H-ras gene expressions in young women with breast
cancer: an immunohistochemical study. Appl Immunohistochem
Mol Morphol 2000; 8: 12-18.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein
measurement with the Folin phenol reagent. J Biol Chem 1951;
193: 265-275.
- Erel O. A new automated colorimetric method for measuring
total oxidant status. Clin Biochem 2005; 38: 1103-1111.
- Draper HH, HadleyM. Malondialdehyde determination as index
of lipid peroxidation. Methods Enzymol 1990; 186: 421-431.
- Tihan DN, Erbil Y, Seven R, Arkaya S, Türkoğlu U, Hepgül G,
Borucu I. The effect of glutamine on oxidative damage in an
experimental abdominal compartment syndrome model in rats.
Turkish Journal of Trauma and Emergency Surgery 2011; 17: 1-8.
- Hartling L, Liang Y, Lacaze-Masmonteil T. Chorioamnionitis as a
risk factor for bronchopulmonary dysplasia: a systematic review
and metaanalysis. Arch Dis Child Fetal Neonatal Ed 2012; 97:
F8-F17.
- Jónsson B, Li YH, Noack G, Brauner A, Tullus K. Down
regulatory cytokines in tracheobronchial aspirate fluid from
infants with chronic lung disease of prematurity. Acta Paediatr
2000; 89: 1375-1380.
- Keane MP, Strieter RM. The importance of balanced
proinflammatory and anti- inflammatory mechanisms in
diffuse lung disease. Respir Res 2002; 3: 5.
- Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ.
Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar
lavage fluid obtained from infants with chronic lung disease of
prematurity. Pediatr Res 1996; 40: 250-256.
- Paananen R, Husa AK, Vuolteennaho R, Herva R, Kaukola T,
Hallman M. Blood cytokines during the perinatal period in
very premature infants: relationship of inflammatory response
and bronchopulmonary dysplasia. J Pediatr 2009; 154: 39-43.
e3.
- Tayman C, Cekmez F, Kafa IM, Canpolat FE, Cetinkaya M,
Tonbul A, Uysal S, Tunc T, Sarici SU. Protective effects of
Nigella sativa oil in hyperoxia-induced lung injury. Arch
Bronconeumol 2013; 49: 15-21.
- Kettle AJ, Winterbourn CC. Myeloperoxidase: a key regulator
of neutrophil oxidant production. Redox Rep 1997; 3: 3-15.
- Wright RM, Ginger LA, Kosila N, Elkins ND, Essary B,
McManaman JL, Repine JE. Mononuclear phagocyte xanthine
oxidoreductase contributes to cytokine-induced acute lung
injury. Am J Respir Cell Mol Biol 2004; 30: 479-490.
- Lee JW, Davis JM. Future applications of antioxidants in
premature infants. Curr Opin Pediatr 2011; 23: 161-166.
- Albertine KH, Plopper CG. DNA oxidation or apoptosis: will
the real culprit of DNA damage in hyperoxic lung injury please
stand up? Am J Respir Cell Mol Biol 2002; 26: 381-383.
- Manar MH, Brown MR, Gauthier TW, Brown LA. Association
of glutathione-S-transferase-P1 (GST-P1) polymorphisms
with bronchopulmonary dysplasia. J Perinatol 2004; 24: 30.
- Höferl M, Stoilova I, Wanner J, Schmidt E, Jirovetz L, Trifonova
D, Stanchev V, Krastanov A. Composition and comprehensive
antioxidant activity of ginger (Zingiber officinale) essential oil
from Ecuador. Nat Prod Commun 2015; 10: 1085-1090.
- Ghlissi Z, Atheymen R, Boujbiha MA, Sahnoun Z, Makni
Ayedi F, Zeghal K, El Feki A, Hakim A. Antioxidant and
androgenic effects of dietary ginger on reproductive function
of male diabetic rats. Int J Food Sci Nutr 2013; 64: 974-978.
- Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested
acinar development in postsurfactant bronchopulmonary
dysplasia. Hum Pathol 1998; 29: 710.
- Ko JK, Leung CC. Ginger extract and polaprezinc exert
gastroprotective actions by anti-oxidant and growth factor
modulating effects in rats. J Gastroenterol Hepatol 2010; 25:
1861-1868.
- Das KC, Ravi D, Holland W. Increased apoptosis and
expression of p21 and p53 in premature infant baboon model
of bronchopulmonary dysplasia. Antioxid Redox Signal 2004;
6: 109-116.